Lakefront Biotherapeutics N.V. LKFT NASDAQ · Healthcare · Belgium
$33.31 -0.24% -$0.08
Summary
75 / 100 · Bulios Score
What speaks for it
- Out of every 100 EUR of revenue, 86 EUR is left as net profit.
- It earns 18 EUR a year on every 100 EUR of invested capital.
- It holds more cash than debt: 96.3M € against 3.15M €.
- The share price is below the Bulios Fair Price.
What to watch
- Revenue fell by 21% a year over the last 3 years.
- It reports a profit, yet spends more cash than it brings in.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 2.5 EUR for 1 EUR of yearly profit. Over the last five years it was 13.6 EUR on average.
Valuation in detailIs it growing?
Revenue (EUR)
Diluted EPS (EUR)
- Analyst estimate
Revenue grew by 18% a year over 5 years. Over the last 3 years it fell by 21% a year.
Growth in detailDoes it make money?
Very wellWhere 100 EUR of revenue goes
- Cost of sales 4.7 EUR
- Research and development 20 EUR
- Sales and administration 8.9 EUR
- Taxes and other -20 EUR
- Net profit 86 EUR
Net profit, industry median (Biotechnology) -9.2 EUR
Out of every 100 EUR of revenue, 86 EUR is left as net profit.
Profitability in detailIs it financially healthy?
YesOver the last 12 months it spent more cash than it brought in. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 1
- Hold 1
- Sell 0
Today's price within the analysts' price targets
The average target of $35.5 is 6.6% above today's price. 50% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.